Skip to main content
德源药业 logo

德源药业 — Investor Relations & Filings

Ticker · 920735 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 569 across all filing types
Latest filing 2023-10-22 Governance Information
Country CN China
Listing Beijing Stock Exchange 920735

About 德源药业

http://www.pharmdy.com

Deyuan Pharmaceutical specializes in the research, development, production, and commercialization of therapeutic drug preparations. The company focuses on chronic disease management, particularly in the fields of endocrinology and cardiovascular health. Its core product line includes treatments for diabetes, hypertension, and hyperlipidemia, featuring medications such as Metformin Hydrochloride sustained-release tablets, Pioglitazone Hydrochloride, and Valsartan. The organization emphasizes technological innovation and maintains rigorous quality control standards across its manufacturing processes. By leveraging advanced formulation technologies, the company develops high-efficacy pharmaceutical solutions aimed at addressing the long-term needs of patients with metabolic and circulatory disorders.

Recent filings

Filing Released Lang Actions
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '江苏德源药业股份有限公司独立董事工作制度' which translates to 'Independent Director Work System of Jiangsu Deyuan Pharmaceutical Co., Ltd.' It details the rules, responsibilities, nomination, election, and duties of independent directors within the company. It includes references to legal and regulatory frameworks, board meeting procedures, and governance practices. There is no financial data, earnings information, or report publication announcement. The content is focused on governance structure and internal rules related to the board and independent directors. Therefore, this document fits best under the category of Governance Information (CGR). The document length (7989 characters) and detailed content support this classification with high confidence.
2023-10-22 Chinese
关于拟修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding proposed amendments to the company's Articles of Association (公司章程). It includes specific clauses about corporate governance, shareholder rights, board responsibilities, and procedures for meetings and elections. The content is focused on governance structure, board and shareholder meeting procedures, and internal company rules rather than financial results or audit opinions. There is no indication that this is a full annual report, audit report, earnings release, or any other financial report. The document is not a brief announcement or a notice of a report publication but a substantive governance-related document. Therefore, the most appropriate classification is Governance Information (CGR).
2023-10-22 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, and procedures of the board nomination committee, including how directors and senior management are nominated and selected. The document includes meeting results and procedural rules but does not contain financial data, earnings, or audit information. It is a governance-related document describing internal board committee rules and processes. Therefore, it fits the category of Governance Information (CGR). The document length is 2792 characters, which is relatively short but contains substantive governance content rather than just an announcement or summary. Hence, the classification is CGR with high confidence.
2023-10-22 Chinese
变更募集资金用途的公告
Capital/Financing Update Classification · 95% confidence The document is titled as an announcement regarding the change in the use of raised funds by Jiangsu Deyuan Pharmaceutical Co., Ltd. It details the original fundraising, the amounts raised, the usage of the funds, and the proposed changes in the allocation of these funds. It includes specifics about the projects involved, reasons for the changes, and approvals from the board, supervisory committee, and independent directors. The document is a formal announcement about the change in the use of capital raised through share issuance, not a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it concerns updates on the company's fundraising and capital usage.
2023-10-22 Chinese
股东大会制度
Governance Information Classification · 100% confidence The document is titled as the "Shareholders' Meeting Rules" of Jiangsu Deyuan Pharmaceutical Co., Ltd. It details the procedures, powers, and rules governing the company's shareholders' meetings, including the convening, proposal submission, voting, and resolution processes. It is a governance document outlining internal rules and practices related to shareholder meetings rather than a report of financial results, voting outcomes, or announcements of meetings. There is no indication that this is a report of voting results, a proxy solicitation, or an announcement of a meeting. The document is comprehensive and regulatory in nature, focusing on governance practices. Therefore, it fits best under Governance Information (CGR).
2023-10-22 Chinese
股东大会累积投票制实施细则
Governance Information Classification · 95% confidence The document is titled as implementation rules for cumulative voting system at the shareholders' meeting of Jiangsu Deyuan Pharmaceutical Co., Ltd. It details the procedures and regulations for electing directors and supervisors, including nomination, voting, and election principles. The content is about governance rules and shareholder meeting procedures rather than financial results, audit, or announcements of voting results. It is a governance-related document outlining internal rules and procedures for board elections, consistent with governance information filings. The document length is 3436 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Therefore, it fits best under Governance Information (CGR).
2023-10-22 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.